M&A

Charles River Laboratories wraps up $380m acquisition of HemaCare
Pharmaceutical Business Review
Mon, 01/6/20 - 10:25 am
Charles River Laboratories
HemaCare
M&A
cell therapy
Why Biotech Stock ArQule Soared 108% in December
Motley Fool
Sat, 01/4/20 - 07:27 pm
Merck
Arqule
M&A
Illumina scraps $1.2B PacBio takeover amid regulatory pushback
BioPharma Dive
Fri, 01/3/20 - 11:07 pm
Illumina
Pacific Biosciences
M&A
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Endpoints
Fri, 01/3/20 - 10:08 am
uBiome
microbiome
M&A
Psomagen
JNJ
Pulmatrix
lung cancer
Top Biopharma M&As in 2019
BioSpace
Fri, 01/3/20 - 10:06 am
M&A
Bristol-Myers Squibb
Celgene
AbbVie
Allergan
Roche
Spark Therapeutics
Novartis
The Medicines Company
Alkermes
Rodin Therapeutics
Sumitomo Dainippon
Roivant
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
What Happens Next for Illumina and Pacific Biosciences?
Motley Fool
Wed, 01/1/20 - 06:57 pm
Illumina
Pacific Biosciences
M&A
Sanofi beat out 3 suitors and one last-minute bid in its pricey $2.5B Synthorx buyout
Fierce Pharma
Wed, 01/1/20 - 06:54 pm
Sanofi
Synthorx
M&A
immunotherapy
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Reuters
Mon, 12/30/19 - 10:59 am
Astellas
Xyphos Biosciences
M&A
Audentes Therapeutics
2 Biotech Stocks Poised to Soar in 2020
Motley Fool
Mon, 12/30/19 - 10:32 am
Acadia Pharmaceuticals
Axsome Therapeutics
M&A
How Gilead Sciences Is Helping Fund Bristol-Myers Squibb's Celgene Acquisition
Motley Fool
Sun, 12/22/19 - 12:32 am
Bristol-Myers Squibb
Celgene
M&A
J&J Fires up the Surgical Robotics Market with New Verb Deal
Medical Devices and Diagnostics Industry
Fri, 12/20/19 - 12:33 pm
JNJ
robotic surgery
devices
Verb Surgical
Verily
M&A
Charles River Labs to buy HemaCare for $380M, expands in cell therapy market
Biopharma Dive
Thu, 12/19/19 - 06:13 pm
Charles River Laboratories
CRO
HemaCare
cell therapy
M&A
The FTC moves to block DNA sequencer Illumina’s acquisition of PacBio, calling company a ‘monopolist’
Stat
Tue, 12/17/19 - 09:18 pm
FDA
DNA sequencing
Illumina
Pacific Biosciences
M&A
Roche's $4.8B deal for Spark cleared by FTC after long delay
Biopharma Dive
Mon, 12/16/19 - 10:46 pm
Roche
Spark Therapeutics
M&A
FTC
After big M&A year, will pharma move away from massive deals in 2020?
Fierce Pharma
Mon, 12/16/19 - 10:29 pm
M&A
Sanofi
Merck
AbbVie
Allergan
Bristol-Myers Squibb
Celgene
FTC
Could Spark Therapeutics’ merger with Roche finally get the go-ahead?
Pharmaforum
Mon, 12/16/19 - 10:46 am
Spark Therapeutics
Roche
UK
M&A
CMA
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Motley Fool
Mon, 12/16/19 - 10:41 am
Bristol-Myers Squibb
Celgene
M&A
Revlimid
patents
Sanofi Says Its $2.5 Billion Biotech Takeover Is Just the Beginning
Motley Fool
Sun, 12/15/19 - 12:15 am
Sanofi
M&A
immuno-oncology
Lantus
diabetes
3M Sheds Its Drug-Delivery Business
Medical Devices and Diagnostics Industry
Fri, 12/13/19 - 10:56 am
3M
M&A
drug delivery
Altaris Capital

Pages